| Nugahealth Primary Care Llc | |
|
11636 Port Royal Ave Waldorf MD 20602-5193 | |
| (240) 755-1452 | |
| Not Available |
| Full Name | Nugahealth Primary Care Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 11636 Port Royal Ave, Waldorf, Maryland |
| Authorized Official Name and Position | Omobolanle M Adenuga (NURSE PRACTITIONER) |
| Authorized Official Contact | 2407551452 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Nugahealth Primary Care Llc 11636 Port Royal Ave Waldorf MD 20602-5193 Ph: () - | Nugahealth Primary Care Llc 11636 Port Royal Ave Waldorf MD 20602-5193 Ph: (240) 755-1452 |
| NPI Number | 1053959411 |
|---|---|
| Provider Enumeration Date | 12/17/2019 |
| Last Update Date | 12/17/2019 |
| Medicare PECOS PAC ID | 5991134629 |
|---|---|
| Medicare Enrollment ID | O20200401001820 |
News Archive
Australian doctors have been warned about the the quit-smoking drug Champix, according to the Therapeutic Goods Administration (TGA) care must be taken when prescribing Champix (varenicline), because of possible serious side-effects.
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053959411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | Omobolanle M Adenuga |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336796465 PECOS PAC ID: 6800225533 Enrollment ID: I20200401001874 |
News Archive
Australian doctors have been warned about the the quit-smoking drug Champix, according to the Therapeutic Goods Administration (TGA) care must be taken when prescribing Champix (varenicline), because of possible serious side-effects.
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.
› Verified 8 days ago
News Archive
Australian doctors have been warned about the the quit-smoking drug Champix, according to the Therapeutic Goods Administration (TGA) care must be taken when prescribing Champix (varenicline), because of possible serious side-effects.
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."
Duke Medicine researchers have identified a receptor in the nervous system that may be key to preventing epilepsy following a prolonged period of seizures.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.
› Verified 8 days ago
Primal Health Family Practice Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3261 Old Washington Rd Ste 2020, Waldorf, MD 20602 Phone: 240-923-0614 | |
Nalin Mathur Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 11855 Holly Ln Ste 107, Waldorf, MD 20601 Phone: 301-638-2733 Fax: 301-638-3377 | |
Total Health Medical Center, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 12106 Old Line Ctr, Waldorf, MD 20602 Phone: 301-645-8898 Fax: 240-222-3280 | |
Asthma Allergy And Sinus Center, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3600 Leonardtown Road, Suite 103, Waldorf, MD 20601 Phone: 301-843-2223 Fax: 301-705-9720 | |
Hispanic American Pediatrics & Family Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2255 Crain Hwy Ste 107, Waldorf, MD 20601 Phone: 301-818-7272 | |
Ch Md Northern Collaborative Care Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2300 Oxford Shire Ct, Waldorf, MD 20603 Phone: 667-207-7005 Fax: 888-722-4282 |